Arkema expands Shanghai R&D Centre and Symrise invests in India

Arkema has inaugurated the expansion of its Research and Development (R&D) Centre in Shanghai, China. The upgrade increases laboratory space by approximately 20% and introduces new collaborative areas, including an interactive showroom for specialty materials. The expansion aims to strengthen the company’s local capabilities to meet the evolving needs of the Chinese market, which serves as Arkema’s second-largest market.

Separately, Symrise is investing in additional world-scale production capacities in India for Globalide, a biodegradable macrocyclic musk fragrance ingredient. This investment is intended to bolster supply reliability and bring the company closer to high-growth markets in Asia as part of its strategic growth plan.